Clinical trials
Completed Breast Neoplasms trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| G1 Therapeutics, Inc. | 2 |
| Mylan Inc. | 2 |
| Tanvex BioPharma USA, Inc. | 2 |
| Arvinas Inc. | 1 |
| AstraZeneca | 1 |
| EirGenix, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Janssen Research & Development, LLC | 1 |
| Jules Bordet Institute | 1 |
| Peregrine Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 19 |
| Neoplasm Metastasis | 3 |
| Triple Negative Breast Neoplasms | 2 |
| Anemia | 1 |
| Carcinoma, Ductal, Breast | 1 |
| Chemotherapy-Induced Febrile Neutropenia | 1 |
| Neutropenia | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.